Clinical trial NCT06106165: Improving Muslim Women's Uptake of Cancer Screening (IMCAN)
Official title: Improving Uptake of Breast, Bowel and Cervical Cancer Screening Among Muslim Women: a Non-randomised Feasibility Study of a Peer-led, Faith-based Intervention
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Breast Cancer
Bowel Cancer
Cervical Cancer
Keywords: Cancer screening
Breast Cancer
Bowel Cancer
Cervical Cancer
Faith-based intervention
Muslim women
Lead sponsor: University of Sunderland
Sponsor class: OTHER
Collaborators: name: University of Glasgow
First posted: 2023-10-30
Enrollment: 200
Sex: FEMALE
Minimum age (years): 25
Maximum age (years): 74
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland.

The results of this trial will inform the development of a full-scale randomised-controlled trial.

Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.

Detailed description: Low rates of cancer screening among Muslim women puts them at higher risk of death from screening since they do not detect cancer early. This study will work to increase the uptake of cancer screening among Muslim women using two-hour workshops delivered in the community.

The workshops were developed with the help of 10 Muslim women in Scotland. The workshops include four parts:

* A discussion on the barriers and facilitators to breast, cervical and colorectal cancer screening
* A health information session given by a female health provider on cancer screening
* Videos of Muslim women talking about their experiences with cancer screening
* A session given by a female religious scholar to discuss Islamic perspectives on cancer screening.

Another eighteen Muslim women then took part in the workshops; they gave positive feedback on the content of the workshops and how the sessions were delivered.

In the feasibility trial, the workshops will be delivered to 200 Muslim women to find out whether a full-scale randomised-controlled trial can take place. This study will be carried out with the help of 10 Muslim women who will give advice on the content of the workshops and plan for implementation; they will also help with the delivery of the workshops.

It is expected that this study will lead to changes in knowledge and screening uptake among participants.

Eligibility criteria: Inclusion Criteria:

* Women from any ethnicity identifying as Muslim
* Muslim Women aged 25-74 years
* Muslim women living in North East England or Scotland
* Muslim women who are not up-to-date with all cancer screening they are eligible for; women who are up-to-date with one type of screening but not others would be eligible (for example, women might be up-to-date with breast cancer screening but not cervical or bowel cancer screening)

Exclusion Criteria:

* Women who do not identify as Muslim
* Women aged less than 25 years or older than 74 years
* Women who are up-to-date with all the screening they are eligible for
* Women who had either breast, cervical or bowel cancer before as their knowledge of the disease and treatment would differ from other women who do not have any prior experience with the disease
* Women who have had BReast CAncer gene testing and underwent mastectomy and/or hysterectomy

Primary outcomes:
measure: Narrative description of feasibility
timeFrame: 12 months
measure: Recruitment feasibility
timeFrame: Baseline, 5 months, 7 months, 12 months
measure: Screening status of participants and the proportion of participants who were partially/not up to date with screening
timeFrame: Baseline
measure: Retention rate
timeFrame: 6 months, 12 months
measure: Peer educator recruitment feasibility
timeFrame: baseline, 12 months
measure: Feasibility of obtaining screening data
timeFrame: 12 months
measure: Questionnaire response rate
timeFrame: Baseline, 6 months, 12 months
measure: Feasibility of measuring secondary outcomes
timeFrame: Baseline, 6 months, 12 months
measure: Difference on key domains between intervention modalities (online/face to face)
timeFrame: Baseline, 6 months, 12 months
measure: The acceptability of the study engagement process to peer-educators
timeFrame: 12 months
measure: The acceptability of the intervention and its implementation to participants and stakeholders, including intervention components and delivery mode (online/face-to-face)
timeFrame: 12 months
measure: The acceptability of data collection methods used to participants and stakeholders
timeFrame: 12 months
measure: Adherence to protocol
timeFrame: 12 months
Secondary outcomes:
measure: Religious health fatalism questionnaire (RHFQ)
timeFrame: Baseline
measure: Modesty
timeFrame: Baseline
measure: Sociodemographic descriptors
timeFrame: Baseline
measure: Cancer knowledge questions adapted from Cancer Awareness Measures (CAM) by Cancer Research UK
timeFrame: baseline, 6 months and 12 months
measure: Cancer screening behaviour
timeFrame: baseline, 6 months and 12 months
measure: Self-reported screening uptake
timeFrame: baseline, 6 months and 12 months
measure: Actual screening uptake
timeFrame: baseline, 6 months and 12 months
measure: Quality of life measures
timeFrame: Baseline, 6 months, 12 months
Other outcomes:
Locations:
city: Glasgow
country: United Kingdom
facility: University of Glasgow
state: Scotland
city: Sunderland
country: United Kingdom
facility: University of Sunderland
state: Tyne and Wear
Study officials:
References: